Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-03 Purchase |
2025-04-04 7:42 pm |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
496,771 | $20.13 | $10,000,000 | 443,792 (Indirect) |
View |
| 2025-02-10 Purchase |
2025-02-10 4:05 pm |
Sionna Therapeutics Inc. | SION | Thompson Peter A. Director |
550,000 | $18 | $9,900,000 | 3,704,959 (Indirect) |
View |
| 2024-08-26 Sale |
2024-08-28 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director |
83,695 | $13 | $1,088,035 | 8,288,510 (Indirect) |
View |
| 2024-08-21 Sale |
2024-08-23 6:41 pm |
ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director |
868,682 | $13.24 | $11,497,963 | 8,372,205 (Indirect) |
View |
| 2024-01-23 Purchase |
2024-01-25 4:32 pm |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
454,545 | $11 | $4,999,995 | 14,756,096 (Indirect) |
View |
| 2023-12-27 Sale |
2023-12-29 4:20 pm |
ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director |
1,546,347 | $18.54 | $28,671,734 | 264,315 (Indirect) |
View |
| 2023-08-29 Purchase |
2023-08-31 5:18 pm |
ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director |
500,000 | $6.2 | $3,100,000 | 9,240,887 (Indirect) |
View |
| 2022-09-16 Purchase |
2022-09-16 4:34 pm |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
484,496 | $10.32 | $4,999,999 | 14,301,551 (Indirect) |
View |
| 2022-05-18 Purchase |
2022-05-20 4:32 pm |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
138,000 | $7.21 | $994,980 | 13,817,055 (Indirect) |
View |
| 2021-12-29 Sale |
2021-12-30 8:55 pm |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
40,400 | $20.3 | $820,120 | 231,098 (Indirect) |
View |
| 2021-12-21 Sale |
2021-12-23 4:08 pm |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
119,400 | $19 | $2,268,600 | 234,798 (Indirect) |
View |
| 2021-12-16 Sale |
2021-12-17 5:16 pm |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
393,300 | $19.07 | $7,500,231 | 245,898 (Indirect) |
View |
| 2021-09-20 Sale |
2021-09-22 5:24 pm |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
1,109,644 | $6.09 | $6,757,732 | 6,943,654 (Indirect) |
View |
| 2021-09-17 Purchase |
2021-09-21 6:38 pm |
ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director 10% Owner |
1,010,637 | $9.4 | $9,499,988 | 425,531 (Indirect) |
View |
| 2021-06-15 Purchase |
2021-06-16 6:20 pm |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
705,853 | $17 | $11,999,501 | 282,398 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-10 Conversion |
2025-02-10 4:05 pm |
N/A N/A |
Sionna Therapeutics Inc. | SION | Thompson Peter A. Director |
7,764,670 | $0 | 3,704,959 (Indirect) |
View |
Ownership |
2025-02-06 9:06 pm |
N/A N/A |
Sionna Therapeutics Inc. | SION | Thompson Peter A. Director |
0 | $0 | 3,154,959 (Indirect) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:00 pm |
N/A 2034-06-19 |
ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-17 4:41 pm |
N/A 2034-06-13 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 6,958,654 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-12 7:33 pm |
2025-06-10 2034-06-10 |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
20,594 | $0 | 20,594 (Direct) |
View |
| 2024-05-18 Equity Swap |
2024-05-20 8:09 pm |
N/A N/A |
ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director |
2,680,496 | $0 | 0 (Indirect) |
View |
| 2024-01-11 Exercise |
2024-01-16 4:36 pm |
N/A N/A |
ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director |
145,251 | $12.74 | 2,680,496 (Indirect) |
View |
| 2024-01-11 Exercise |
2024-01-16 4:36 pm |
2019-01-18 2024-01-18 |
ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director |
145,251 | $0 | 2,680,496 (Indirect) |
View |
| 2024-01-02 Option Award |
2024-01-04 7:02 pm |
N/A 2034-01-01 |
ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-12-06 Option Award |
2023-12-08 4:02 pm |
N/A 2033-12-06 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 6,958,654 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-28 9:00 pm |
N/A 2033-06-26 |
ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director 10% Owner |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 5:03 pm |
N/A 2033-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 6,958,654 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 7:29 pm |
2024-06-12 2033-06-12 |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
22,123 | $0 | 22,123 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 7:07 pm |
N/A 2033-01-02 |
ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-08-11 Option Award |
2022-08-15 6:47 pm |
N/A 2032-08-11 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 6,958,654 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 7:17 pm |
2023-06-08 2032-06-24 |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
42,087 | $0 | 42,087 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 6:54 pm |
N/A 2032-06-16 |
Decibel Therapeutics Inc. | DBTX | Thompson Peter A. Director 10% Owner |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:35 pm |
N/A 2032-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 6,958,654 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:35 pm |
N/A 2032-06-13 |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:52 pm |
N/A 2032-06-09 |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 5:19 pm |
N/A 2032-01-02 |
ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director 10% Owner |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-09-21 5:14 pm |
N/A 2031-06-03 |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-09-09 Option Award |
2021-09-13 4:53 pm |
N/A 2031-09-09 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 8,068,298 (Direct) |
View |
| 2021-06-15 Conversion |
2021-06-16 6:20 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
4,161,198 | $0 | 282,398 (Indirect) |
View |
| 2021-06-15 Option Award |
2021-06-16 4:15 pm |
N/A 2031-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 8,068,298 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:43 pm |
N/A 2031-06-09 |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director 10% Owner |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2021-06-10 7:22 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
0 | $0 | 2,336,911 (Indirect) |
View |